Table 6.
Characteristics | Survivors | Non-survivors | p-values |
---|---|---|---|
Demographics | |||
Age, mean, year (SD) | 67.33 ±13.99 | 71.85 ±16.77 | |
Male sex (%) | 22 | 33 | NS |
LOS prior to event, median, days (SD) | 12.3 ±11.65 | 22.41 ±18.05 | 0.002 |
Comorbidities (%) | |||
Hypertension | 22 | 39 | NS |
Malignancies | |||
Hematologic | 6 | 13 | NS |
Solid | 10 | 11 | NS |
Diabetes mellitus | 5 | 21 | 0.044 |
Coronary artery disease | 11 | 14 | NS |
Congestive heart failure | 4 | 6 | NS |
Renal disease | 2 | 13 | NS |
Dyslipidemia | 4 | 7 | NS |
Autoimmune diseases | 2 | 4 | NS |
Lung disease | 7 | 11 | NS |
Cerebral vascular accident | 2 | 4 | NS |
Neutropenia | 3 | 10 | NS |
High dose steroids | 9 | 44 | <0.001 |
Invasive procedures prior to event (%) | |||
Foley | 21 | 47 | NS |
Central lines | 19 | 49 | NS |
Nasogastric tube | 11 | 29 | NS |
Mechanical ventilation | 8 | 32 | 0.005 |
Drains | 7 | 12 | NS |
Tracheostomy | 1 | 6 | NS |
Total parenteral nutrition | 5 | 11 | NS |
CC unit stay | 16 | 44 | 0.03 |
XDR profile | 28 | 54 | NS |
Infection source | |||
Primary | 22 | 35 | NS |
Secondary | 10 | 23 | |
Prior exposure to colistin and/or tigecycline | 4 | 21 | 0.019 |
Septic shock at time of acquisition | 2 | 39 | <0.001 |
SD, standard deviation; LOS, length of stay; CC, critical care.